Evidence map›Paper›PMID 34959593›Full record

ReviewPathogens (Basel, Switzerland)2021

β-lactam Resistance in

Karl A Glen, Iain L Lamont

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Antibiotic resistance mechanisms and global resistance patterns of Pseudomonas aeruginosa in microbial keratitis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  6. Multidrug-resistant Pseudomonas aeruginosa in ICU patients and hospital surfaces: β-lactamase burden, biofilm formation and clonal spread.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Molecular Mechanisms Underlying the Pathogenicity ofMedicina (Kaunas, Lithuania) · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Mechanisms ofMedicina (Kaunas, Lithuania) · 2026
    Review
  19. Genomic Analysis ofInternational journal of microbiology · 2026
    Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Karl A GlenDepartment of Biochemistry, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand.ORCID 0000-0002-9370-3893
Iain L LamontDepartment of Biochemistry, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand.ORCID 0000-0002-7601-6354
University of Otago · NZ

Funding

Health Research Council of New Zealand 17/372 and 20/812
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmpCantibiotic effluxantibiotic resistancecarbapenemcarbapenemasecephalosporincystic fibrosisnosocomial infectionPBP3β-lactamase

Identifiers

PMID34959593
PMCPMC8706265
OpenAlexW4200393513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.